Purpose
To use the large data set from the recently completed ESCUDDO trial to try and better identify the immunological features that may distinguish vaccine failures from individuals who were protected by the HPV vaccine.
Grantee
Division
Global Health
Date
DECEMBER 2025
Region served
GLOBAL
Committed amount
$770,281
Grant topic
Vaccine Development
Duration (months)
23
Grantee location
Bethesda, Maryland, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.